Talk to us.

Keeping Mothers and Babies Safe During Childbirth

Dr. Mary-Ann Etiebet (Executive Director of Merck for Mothers, Merck’s 10-year $500m initiative to create a world where no woman dies while giving birth) said, “The United States is the only industrialized country where the rates of maternal deaths have increased, not decreased. Young women actually have a higher risk of dying during pregnancy and childbirth than their mothers did. The United States is ranked 46th when it comes to maternal mortality. That’s behind countries like Saudi Arabia and Kazakhstan.” In the U.S., at least two pregnant and/or delivering women die per day. The “near deaths” amount to 60,000 a year.

 

Quick Facts for Investors

Location San Ramon, CA
VCapital Invested 2019
CEO Neil Ray, MD
Founded 2016
Founded By Neil Ray, MD
Industry Medical Device (diagnostic)

Why We Invested

C-sections are currently performed on 33% of deliveries. Hospitals are now being penalized for rates of over 23.9%. Once approved, four million births per year in the U.S. will be using Raydiant’s technology.

Raydiant has already received non-diluted funding from the NIH and NSF. We believe that in 5-10 years, Raydiant’s technology will be common practice in most deliveries.

Our confidence in the CEO and his experience is strong.

 

“It is not an easy task for a founder to get VCapital to lead your Series A. They evaluate over 1,200 deals per year and make just a handful of investments. They drill deep into your business before committing to invest. But at the end of the process, you will experience tremendous growth as a founder and have an amazing VC partner for life.”

~Neil Ray, MD and CEO of Raydiant

News and Updates

September 24, 2024
Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
June 4, 2024
Raydiant Oximetry Oversubscribes Series A $7.5 Million Extension Round
April 11, 2024
FDA approves trial of system to measure baby’s oxygen during labour
April 10, 2024
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
July 27, 2023
Raydiant nominated for best startup in MedTech
July 5, 2023
Improving Maternal Health Outcomes Starts with Reducing Unnecessary C-Sections
May 31, 2023
The Top Founders & Leaders Driving Innovation In Women’s Health Of 2023
May 31, 2023
Raydiant Oximetry was featured as one of the top 50 Women’s Health Companies Driving Innovation in 2023
April 4, 2023
The worsening state of the United States' maternal healthcare
March 16, 2023
US maternal death rate rose sharply in 2021
March 6, 2023
Women’s Health Care Is Underfunded. The Consequences Are Dire.
March 6, 2023
Meet the woman who invented a whole new subsection of tech set to be worth $1 trillion
February 7, 2023
Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes
July 28, 2022
NIH announces prize winners of maternal health diagnostics challenge
November 2, 2021
Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study
May 2, 2021
Raydiant Oximetry Receives $3 Million Grant to Advance Its Innovative Technology
October 6, 2020
Raydiant Oximetry selected for 2020 HealthTech Arkansas early-stage accelerator program.
September 10, 2020
MedTech Innovator Best Video Competitions